InvestorsHub Logo
Post# of 252997
Next 10
Followers 13
Posts 325
Boards Moderated 0
Alias Born 01/15/2008

Re: DragonBits post# 79127

Friday, 06/05/2009 9:37:20 PM

Friday, June 05, 2009 9:37:20 PM

Post# of 252997
As far as biotech stock prices go DNDN was at $2.50 a share not more than 2-3 months ago. I remember when ELN was in the $3s before running up to $35 within 24 months, stayed around $8 forever on the way, and it is back down to the $7s now. VRTX fell to $14 on nothing but market manipulation, no other way to explain that.

Long and short is to figure out what a biotech is really worth, then take advantage of market inefficiencies, manipulations, overreactions, market collapses etc., and then have a heck of a lot of patience. Of course this FDA Lovenox approval process is ridiculous. I have the feeling the U.S. Government is going to be desperately in need of generic biologicals such as Lovenox. Dew's latest back of the envelopes showed $500 million per year saved in the U.S. by generic Lovenox alone, multiply that many times over and it might even equal a blip on the medical cost spending spreadsheet, which is better then any of the other so called "cost saving" provisions being bandied about. So it has to happen. I say this year, but yes, could be next year and if so that will be awfully, awfully frustrating to say the least.

Tinker
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.